AeroClave Logo.png
AeroClave Onboards New Channel Partner, Hunter Apparatus
February 20, 2024 09:03 ET | AeroClave
WINTER PARK, Fla., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Leading decontamination technology provider, AeroClave today announces its lucrative channel partnership with Hunter Apparatus, an authorized...
image (5).png
Qure.ai adds new FDA breakthrough device status to growing list of regulatory milestones
February 05, 2024 09:00 ET | Qure.ai Technologies Private Limited
NEW YORK, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Medical imaging AI innovator, Qure.ai, has received breakthrough device designation from the Food and Drug Administration's (FDA) Center for Devices and...
84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Wearable Sensors Market Expected to Reach USD 10.19 Billion by 2033 | Impressive CAGR of 12.8%
January 29, 2024 03:51 ET | Market.Us
New York, Jan. 29, 2024 (GLOBE NEWSWIRE) -- According to Market.us, The Wearable Sensors market size is expected to be worth around USD 10.19 Billion by 2033 from USD 3.55 Billion in 2023, growing...
AeroClave Logo.png
AeroClave Offers New Funding Path for Industrial Decontamination Solution With GovFunds
January 23, 2024 09:00 ET | AeroClave
WINTER PARK, Fla., Jan. 23, 2024 (GLOBE NEWSWIRE) -- AeroClave, a leading provider in decontamination technology, today announces its partnership with GovFunds to provide prospective customers...
website-logo (2).png
Cell Therapy Technologies Market Projected to Reach Valuation of USD 47.3 Billion at 24.7% CAGR from 2024-2033 | Marketresearch.biz Study
January 16, 2024 02:33 ET | MarketResearch.biz
New York, Jan. 16, 2024 (GLOBE NEWSWIRE) -- In 2023 Cell therapy technologies market were valued at USD 5.5 billion in 2023 with significant growth and are projected to reach USD 47.3 billion by...
84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Personal Health Record Software Market to Exceed USD 21.7 Billion by 2033; Amid Rising Popularity of Digital Health Solutions and Patient-Centric Healthcare
January 08, 2024 07:31 ET | Market.Us
New York, Jan. 08, 2024 (GLOBE NEWSWIRE) -- According to market.us, the Personal Health Record Software Market is expected to achieve a valuation of approximately USD 21.7 Billion by 2033,...
logo.png
Nexstim receives Nexstim NBS System 5 order from Distributor in Europe
December 29, 2023 03:00 ET | Nexstim Oyj
Press release, Helsinki, 29 December 2023 at 10 AM (EEST) Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an order for an NBS System 5 from a distributor company based in Europe. ...
akido_logo (1).png
Rhode Island Primary Care Physicians Corporation Announces Joint Venture with Akido Labs
December 21, 2023 10:05 ET | Akido Labs
This Joint Venture is Marked by the Creation of Bicoastal Health Care Innovation Hubs Designed to Develop Best Practices in Care
Replay_Logo_Black_CMYK.png
Replay and its engineered NK cell therapy company Syena announce exclusive licensing agreement with National Institutes of Health for TCRs targeting cancer neoantigens
December 18, 2023 07:00 ET | Replay Bio
Replay and its engineered NK cell therapy company Syena announce exclusive licensing agreement with National Institutes of Health for TCRs targeting cancer neoantigens Replay and its...
Replay_Logo_Black_CMYK.png
Replay’s oncology-focused product company Syena and Miltenyi Biotec enter into exclusive licensing and GMP manufacturing agreement for PRAME TCR-NK cell therapy based on CliniMACS Prodigy®
December 18, 2023 07:00 ET | Replay Bio
Replay’s oncology-focused product company Syena and Miltenyi Biotec enter into exclusive licensing and GMP manufacturing agreement for PRAME TCR-NK cell therapy based on CliniMACS Prodigy® Syena...